Journal of Data Mining in Genomics & Proteomics

Understanding the Complexities of Gene-Gene Interactions in Hypertension

Wu Tong^* Department of Genomics and Proteomics, Chang Gung University, Kaohsiung, Taiwan
^*Correspondence: Wu Tong, Department of Genomics and Proteomics, Chang Gung University, Kaohsiung, Taiwan, Email:

Received: 26-Dec-2023, Manuscript No. JDMGP-24-24508; Editor assigned: 29-Dec-2023, Pre QC No. JDMGP-24-24508 (PQ); Reviewed: 12-Jan-2024, QC No. JDMGP-24-24508; Revised: 19-Jan-2024, Manuscript No. JDMGP-24-24508 (R); Published: 26-Jan-2024, DOI: 10.4172/2153-0602.24.15.337

Description

Hypertension, or high blood pressure, is a multifaceted health condition affecting millions worldwide. While the influence of individual genes on hypertension is recognized, recent research has shifted focus to explore the complex interplay between multiple genes [1]. This exploration of gene-gene interactions explores the complex genetic landscape underlying hypertension, providing insights into its underlying mechanisms and potential paths for personalized treatments.

The genetic basis of hypertension

Genetic factors play a significant role in the development of hypertension. Studies have identified numerous genes associated with blood pressure regulation, vascular function, and sodium handling [2]. However, the complexity of hypertension extends beyond individual genes, prompting researchers to investigate how these genes interact with each other, leading to a more comprehensive understanding of the condition.

The complexity of gene-gene interactions

Hypertension is a polygenic disorder, means it involves variations in multiple genes. Gene-gene interactions, also known as epistasis, refer to the ways in which the effects of one gene are modified by one or more other genes [3]. These interactions may be synergistic, antagonistic, or even conditional, creating a complex network of genetic relationships that contribute to an individual's blood pressure regulation.

Exploring synergistic interactions

Certain combinations of genes may amplify the risk of hypertension beyond what would be expected from each gene individually. For instance, variations in genes related to the renin-angiotensin-aldosterone system, when combined with specific endothelial function genes, might create a synergistic effect, increasing the probability of hypertension [4]. Understanding these synergistic interactions requires sophisticated analyses that consider the collective impact of various gene variants.

Antagonistic interactions in blood pressure regulation

In contrast, some gene-gene interactions may have an antagonistic effect, where variations in one gene counteract the impact of another [5]. For instance, a gene associated with vasodilation might interact antagonistically with a gene linked to vasoconstriction, creating a delicate balance in blood pressure regulation. Understanding these interactions is potential for explaining the complex genetic influences on hypertension [6].

Conditional interactions and environmental factors

Gene-gene interactions can also be conditional, meaning their effects depends on specific environmental factors. Lifestyle choices, such as diet, exercise, and exposure to stress, can modify the influence of certain gene variants on blood pressure. Investigating these conditional interactions provides a more holistic understanding of how genetics and environment jointly contribute to hypertension risk [7].

Challenges in studying gene-gene interactions

While the exploration of gene-gene interactions holds potential, it comes with challenges. Large-scale studies with diverse populations are necessary to capture the complexity of genetic variations and their interactions. Additionally, advanced computational approaches are required to analyze vast datasets and identify subtle interactions among numerous genes [8].

Implications for personalized medicine

Understanding gene-gene interactions in hypertension has profound implications for personalized medicine. By explaining an individual's unique genetic profile and how their genes interact, healthcare providers can alter interventions to address specific genetic susceptibilities. This approach holds potential for more effective and targeted treatments, moving away from the traditional one-size-fits-all approach [9].

In conclusion, the exploration of gene-gene interactions in hypertension represents a paradigm shift in our understanding of this complex health condition. Moving beyond the examination of individual genes, researchers are exploring the intricate relationships between multiple genetic factors. These interactions, whether synergistic, antagonistic, or conditional, contribute to the complex genetic landscape of hypertension. While challenges persist in studying these interactions, the potential for personalized medicine and targeted interventions predict for more effective hypertension management in the future [10].

References

1. Duijvenboden van S, Ramírez J, Young WJ, Olczak KJ, Ahmed F, Alhammadi MJ, et al. Integration of genetic fine-mapping and multi-omics data reveals candidate effector genes for hypertension. Am. J. Hum. Genet. 2023;110(10):1718-1734.

   [Crossref] [Google Scholar] [PubMed]

2. Mendoza-Carrera F, Farías-Basulto A, Gómez-García EF, Cortés-Sanabria L, Cueto-Manzano AM, Leal-Cortés CA. Association of Serum Fibroblast Growth Factor 23 and FGF23 gene Variants with chronic kidney disease in patients with type 2 diabetes and essential hypertension. Arch. Med. Res. 2023;54(3):239-246.

   [Crossref] [Google Scholar] [PubMed]

3. Wang L, Cheng F, Hu J, Wang H, Tan N, Li S, et al. Pathway-based gene-gene interaction network modelling to predict potential biomarkers of essential hypertension. BioSystems. 2018;172:18-25.

   [Crossref] [Google Scholar] [PubMed]

4. Zhang H, Nie S, Chen Q, Wang P, Xu C, Tu X, et al. Gene polymorphism in IL17A and gene-gene interaction in the IL23R/IL17A axis are associated with susceptibility to coronary artery disease. Cytokine. 2023;164:156142.

   [Crossref] [Google Scholar] [PubMed]

5. Fu L, Zhang M, Hu YQ, Zhao X, Cheng H, Hou D, et al. Gene-gene interactions and associations of six hypertension related single nucleotide polymorphisms with obesity risk in a Chinese children population. Gene. 2018 Dec 30;679:320-327.

   [Crossref] [Google Scholar] [PubMed]

6. Wang MH, Li J, Yeung VS, Zee BC, Yu RH, Ho S, et al. Four pairs of gene–gene interactions associated with increased risk for type 2 diabetes (CDKN2BAS–KCNJ11), obesity (SLC2A9–IGF2BP2, FTO–APOA5), and hypertension (MC4R–IGF2BP2) in Chinese women. Meta Gene. 2014;2:384-391.

   [Crossref] [Google Scholar] [PubMed]

7. Xu Z, Zhang D, Lin J, Li X, Liu Y, Gao J, et al. The influence of CYP2R1 polymorphisms and gene–obesity interaction with hypertension risk in a Chinese rural population. Nutr Metab Cardiovasc Dis. 2022;32(1):241-248.

   [Crossref] [Google Scholar] [PubMed]

8. Huang LJ, Zhang QX, Valenzuela RK, Xu JC, Yan F, Ma J. Identifying susceptibility genes for essential hypertension by transcriptome-wide association study. Biochem. Biophys. Rep. 2022;32:101387.

   [Crossref] [Google Scholar] [PubMed]

9. Sharif NA. Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma. Mol. Aspects Med. 2023;94:101218.

   [Crossref] [Google Scholar] [PubMed]

10. Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, et al. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension. Genet Med. 2023;25(11):100925.

    [Crossref] [Google Scholar] [PubMed]